Atrial Fibrillation Burden and Clinical Outcomes in Heart Failure

医学 心房颤动 危险系数 临床终点 内科学 导管消融 心力衰竭 心脏病学 置信区间 烧蚀 随机对照试验 比例危险模型 前瞻性队列研究 临床试验
作者
Johannes Brachmann,Christian Sohns,Dietrich Andresen,Jürgen Siebels,Susanne Sehner,Lucas V.A. Boersma,Béla Merkely,Evgeny Pokushalov,Prashanthan Sanders,Heribert Schunkert,Dietmar Bänsch,Lilas Dagher,Yan Zhao,Christian Mahnkopf,Karl Wegscheider,Nassir F. Marrouche
出处
期刊:JACC: Clinical Electrophysiology [Elsevier BV]
卷期号:7 (5): 594-603 被引量:202
标识
DOI:10.1016/j.jacep.2020.11.021
摘要

This subanalysis of the CASTLE-AF (Catheter Ablation vs. Standard Conventional Treatment in Patients With LV Dysfunction and AF) trial aimed to address the association between atrial fibrillation (AF) recurrence, AF burden, and hard clinical outcomes in heart failure (HF) patients with AF.The CASTLE-AF trial demonstrated the benefit of CA compared to pharmacological treatment in decreasing mortality and CV hospitalizations in patients with AF and HFrEF. However, the impact of AF recurrence and AF burden after ablation on long-term treatment benefit remains unknown.The CASTLE-AF protocol randomized 363 patients with coexisting HF and AF in a multicenter prospective controlled fashion to catheter ablation (n = 179) versus pharmacological therapy (n = 184). Two hundred eighty patients were included in this subanalysis (as-treated), 128 of them underwent ablation and 152 received pharmacological treatment. All patients had implanted dual chamber or biventricular implantable defibrillators with activated home monitoring capabilities. The individual AF burden was calculated as the percentage of the atrial arrhythmia time per day.AF burden at baseline was not predictive of the primary endpoint (p = 0.473) or all-cause mortality (p = 0.446). AF recurrence (defined as any episode >30 s) did not show any relationship with the primary endpoints of mortality and occurrence of HF, irrespective of the treatment arm. An AF burden below 50% after 6 months of catheter ablation, was associated with a significant decrease in primary composite outcome (hazard ratio [HR]: 0.33; 95% confidence interval [CI]: 0.15 to 0.71; p = 0.014) and all-cause mortality (HR: 0.23; 95% CI: 0.07 to 0.71; p = 0.031). The risk of the primary endpoint or mortality was directly related to a low (<50%) or high (≥50%) AF burden at 6 months post-ablation.AF burden at 6 months was predictive of hard clinical outcomes in HF patients with AF. The first recurrent atrial tachyarrhythmia episode >30 s after ablation was not associated with improvement in mortality and hospitalization for HF. (Catheter Ablation vs. Standard Conventional Treatment in Patients With LV Dysfunction and AF [CASTLE-AF]; NCT00643188).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
谷咕咕完成签到,获得积分10
刚刚
瓦达西瓦完成签到,获得积分10
1秒前
元复天完成签到 ,获得积分10
1秒前
Tang发布了新的文献求助10
1秒前
ha完成签到 ,获得积分10
2秒前
ppppp完成签到,获得积分10
2秒前
a水爱科研完成签到,获得积分10
2秒前
吴梦丽完成签到,获得积分10
2秒前
段甜完成签到 ,获得积分10
2秒前
Cherish完成签到,获得积分10
2秒前
媛媛完成签到,获得积分10
3秒前
zhangwenkang完成签到,获得积分10
3秒前
xhntt完成签到,获得积分10
3秒前
3秒前
开朗依柔完成签到,获得积分10
4秒前
CaiLing完成签到 ,获得积分10
4秒前
所所的应助被小王采纳,获得10
4秒前
碧落潮汐完成签到 ,获得积分10
4秒前
hehe完成签到,获得积分10
5秒前
天工王晨屹完成签到 ,获得积分10
5秒前
5秒前
丰富的甜瓜完成签到,获得积分10
5秒前
sengseng完成签到,获得积分10
5秒前
csy发布了新的文献求助10
5秒前
fanch1122完成签到,获得积分10
5秒前
淡定采波完成签到,获得积分10
6秒前
Apollo879完成签到,获得积分10
6秒前
6秒前
fantasy的应助被纯情的凡双采纳,获得10
6秒前
6秒前
天才完成签到,获得积分10
6秒前
睿力完成签到,获得积分10
7秒前
Robin007完成签到,获得积分10
7秒前
北岭梅花香到骨完成签到,获得积分10
7秒前
ELITOmiko完成签到,获得积分10
7秒前
小曾最棒啦完成签到 ,获得积分10
8秒前
个性的半梅完成签到,获得积分10
8秒前
Aixx完成签到 ,获得积分10
8秒前
hq完成签到,获得积分20
8秒前
风暴战斧完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180275
求助须知:如何正确求助?哪些是违规求助? 9570366
关于积分的说明 21810725
捐赠科研通 7776380
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479042